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The mammalian lymphatic system consists of strategically located lymph nodes (LNs) embedded into a lymphatic vascular 
network. Mechanisms underlying development of this highly organized system are not fully understood. Using high-
resolution imaging, we show that lymphoid tissue inducer (LTi) cells initially transmigrate from veins at LN development 
sites using gaps in venous mural coverage. This process is independent of lymphatic vasculature, but lymphatic vessels 
are indispensable for the transport of LTi cells that egress from blood capillaries elsewhere and serve as an essential 
LN expansion reservoir. At later stages, lymphatic collecting vessels ensure efficient LTi cell transport and formation of 
the LN capsule and subcapsular sinus. Perinodal lymphatics also promote local interstitial flow, which cooperates with 
lymphotoxin-β signaling to amplify stromal CXCL13 production and thereby promote LTi cell retention. Our data unify 
previous models of LN development by showing that lymphatics intervene at multiple points to assist LN expansion and 
identify a new role for mechanical forces in LN development.
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Introduction
Lymphatic capillaries take up interstitial fluid, antigens, and 
antigen-presenting cells, and collecting vessels transport 
lymph to LNs. Afferent collecting lymphatics deliver lymph 
to the LN subcapsular sinus (SCS) through a fibrous capsule 
surrounding LNs. From the SCS, lymph reaches trabecular and 
medullary lymphatic sinuses and exits via the efferent collect-
ing vessels. The LN and peripheral lymphatic endothelial cells 
(LECs) are molecularly distinct (Petrova and Koh, 2018). Such 
specialization is important for intranodal migration of den-
dritic cells (DCs; Ulvmar et al., 2014), filtration of small versus 
large molecular weight components (Rantakari et al., 2015), 
and immune tolerance (Cohen et al., 2010; Lund et al., 2012; 
Tewalt et al., 2012).
Mechanisms of how such a highly organized system arises 
during development are not fully understood. Pioneering stud-
ies have identified key roles for hematopoietic lymphoid tissue 
inducer (LTi) and stromal lymphoid tissue organizer (LTo) cells, 
proposing a model where LNs are initiated after CXCR5+ pre-LTi 
cell egress to specific locations from blood vessels in response to 
LTo cell-derived CXCL13 (Ansel et al., 2000; Mebius et al., 2001; 
Yoshida et al., 2001; Luther et al., 2003; Ohl et al., 2003; van de 
Pavert et al., 2009; van de Pavert and Mebius, 2010; Brendolan 
and Caamaño, 2012). Clustering and crosstalk of LTαβ+ LTi and 
LTβR+ (lymphotoxin-β receptor) LTo cells result in further signal 
amplification, leading to LTi cell maturation and accumulation. 
Analysis of Prox1−/− embryos, which lack lymphatic vessels, re-
vealed that most LNs are initiated in the absence of lymphatics, 
but their expansion is compromised (Vondenhoff et al., 2009b). 
Accordingly, Vegfc+/− embryos with defective lymphangiogenesis 
have small LNs (Lee and Koh, 2016). Recently, Onder et al. (2017) 
demonstrated that LEC-specific loss of LTβR and RANK impaired 
LN formation and proposed an alternative model, in which lym-
phatics initiate LNs by bringing disseminated LTi cells to the LN 
development site. The mechanism of LN capsule and SCS forma-
tion is also enigmatic. The SCS, the site of arrival of lymph and 
DCs, hosts resident phagocytes filtering pathogens and particles 
from the afferent lymph and is continuous with afferent collect-
ing lymphatics. Currently, it is not known whether collecting 
lymphatic vessel development and maturation is linked to LN 
capsule and SCS formation.
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We propose that early LN development comprises both LTi 
cell egress from the veins, occurring independently of lymphatic 
vessels, and lymphatic transport of disseminated LTi cells to the 
LN site. We further show that efficient LTi cell transport, for-
mation of the LN capsule, and specialization of the SCS at later 
embryonic stages require collecting lymphatic vessels. Perinodal 
lymphatics also promote local interstitial flow, which amplifies 
CXCL13 expression by LTo cells in cooperation with lymphotox-
in-β signaling and thereby promotes LTi cell retention. Our data 
reveal a new role of mechanical forces in LN development and 
provide a unified model in which lymphatic vessels intervene at 
multiple points to assist LN expansion.
Results
Lymphatic vasculature remodeling at the site 
of LN development
Mouse embryonic lymphatic vessels first form a capillary-like 
plexus (Escobedo and Oliver, 2016), and at E15.5–E16.5, in re-
sponse to increased lymph flow, part of this plexus matures into 
collecting vessels, characterized by low levels of LYVE1 and VEG 
FR3 and presence of intraluminal valves (Mäkinen et al., 2005; 
Norrmén et al., 2009; Sabine et al., 2012, 2015). We visualized 
remodeling of LN-associated lymphatic vessels using whole 
mount imaging of inguinal LNs (iLNs) at different stages of em-
bryogenesis. At E15.5, as described earlier (Eberl et al., 2004; 
Vondenhoff et al., 2009b), single extravascular CD4+ LTi cells and 
aggregates accumulated at bifurcations of the inguinal blood ves-
sels, beneath the subepigastric vein/artery and above lymphatic 
vessels (Fig. 1, A and B). At E16.5, the lymphatic vessel beneath 
the LN anlage expanded and formed a shallow disk (Fig.  1  B). 
The disk progressively enlarged, forming a cup-like structure 
around growing CD4+ LTi cell area, and almost fully engulfed 
it by E20–E20.5 (Fig. 1 B). While both peripheral and LN LECs 
express VEG FR3, NRP2 important for LEC sprouting (Xu et al., 
2010) was detected only on peripheral LECs. The NRP2 was low 
in the lymphatic cup around LN anlage and was expressed only 
in few sprouting LECs at the cup edge (Fig. 1, C and D). 20% of 
LECs proliferated in the lower part of the cup, and this proportion 
increased to 30% in the upper part (Fig. 1, E, E′, and F). Lymphatic 
vessel expansion around the LN anlage is thus a process distinct 
from lymphatic vessel growth occurring in skin. In the former 
case, we observed a coordinated extension of continuous double 
LEC layers, which eventually engulfs the LN anlage. In contrast, 
peripheral lymphatic vessels display multiple sprouts and form 
a mesh-like network (Fig. 1 G).
Extracellular matrix and smooth muscle cells (SMCs) 
surround embryonic LNs
At E18.5, SMCs were associated with the exterior LN LECs and 
closely followed the expanding LEC sheet (Fig. 2, A and A′), in-
dicating coordinated formation of the LN capsule. Staining for 
collagen IV revealed increased extracellular matrix deposition 
around the LN capsule (Fig. 2 B). PDGFβ, a growth factor essential 
for vascular SMC recruitment (Wang et al., 2017), was expressed 
by the outer LEC layer (Fig. 2 C). Taken together, our data demon-
strate that the growing LN induces a coordinated remodeling and 
expansion of adjacent lymphatic vessels. As a result, the newly 
formed lymphatic cup envelops the developing LN while main-
taining overall vessel integrity and function (Fig. 2 D).
LN initiation and early expansion require both blood and 
lymphatic vessels
Earlier models proposed that LNs are formed by RORγt+ CD4− 
CXCR5+ pre-LTi cells exiting from blood vessels in response to 
CXCL13 produced by fibroblastic LTo cells (van de Pavert et al., 
2009, 2014). Onder et al. (2017) suggested that lymphatic vessels 
initiate LN formation by transporting LTi cells to the LN site and 
by increasing LTi cell retention through CCL21+ perinodal lym-
phatics. To characterize the LN initiation process in more detail 
we first visualized the localization of CD4+ LTi cells and blood 
vessels at different development stages by staining for αSMA (α-
smooth muscle actin), the venous marker endomucin, and the 
basement membrane component laminin α5. We observed sig-
nificantly higher SMC coverage of the subepigastric vein at the 
iLN site at E16.5 in comparison to E15.0 (Fig. 3, A–C). At E15.0, only 
arteries produced laminin α5, which inhibits the T cell egress 
from blood vessels (Wu et al., 2009; Fig. 3 B). We also observed a 
strikingly different SMC coverage of the subepigastric vein along 
the anterior–posterior axis: the vein in the axillary region had 
a continuous SMC layer, but SMCs at the venous bifurcation in 
the iLN area were so sparse that it was difficult to detect the vein 
contour (Fig. 3, C–E). In contrast, we observed high laminin α5 
deposition and complete venous SMC coverage in both locations 
after E16.5 (Fig. 3, B and C). Importantly, at E15, we observed LTi 
cell trafficking in SMC-low gaps in the venous EC layer (Fig. 3, F 
and F′). Significantly, we did not observe CD4+ LTi cells in the ve-
nous lumen. Because CD4 marks mature LTi cells (van de Pavert 
et al., 2009, 2014), we analyzed E15.0 Rorc(γt)EGFP/+ embryos, in 
which both RORγt+ CD4− pre-LTi and mature RORγt+ CD4+ LTi 
cells can be observed. Indeed, only a proportion of extravascular 
iLN RORγt+ cells was CD4+ (Fig. S1, A and B). Most importantly, 
we observed intravenous RORγt+ cells in the iLN area in close 
contact with ECs (Fig. S1, C and C′). These results are consistent 
with the model in which immature RORγt+ CD4− LTi cells egress 
from the vein and undergo further extravascular maturation.
To study if LTi cell transmigration alters venous SMC cov-
erage, we analyzed Id2-deficient embryos, which lack LTi cells 
(Fig. S1, D–F; Yokota et al., 1999; Rawlins et al., 2009). Venous 
SMC coverage was still reduced in the iLN regions in these mice 
(Fig. S1, D–F); therefore, low SMC coverage is an intrinsic char-
acteristic of the vein at this location at E15. Finally, we analyzed 
Pdgfbret/ret embryos, which have low perivascular Pdgfβ and 
reduced recruitment of mural cells to blood vessels (Lindblom 
et al., 2003). The iLNs were significantly bigger in Pdgfbret/ret 
embryos in comparison to the controls, indicating that SMC cov-
erage of blood vessels is an important factor regulating LN devel-
opment (Fig. 3, G and H). These results support the notion that 
during LN initiation, pre-LTi cells egress at LN development sites 
using gaps in venous mural coverage and then undergo further 
local maturation.
To study whether lymphatic vasculature is necessary for pre-
LTi cell egress from the vein, we blocked lymphangiogenesis by 
administering VEG FR3-blocking antibodies. In agreement with 
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Figure 1. Lymphatic vessel remodeling during LN development. (A) LTi cells accumulate between lymphatic vessels and the subepigastric vein. Whole 
mount and frontal view (10 µm) of iLN: CD4 (green), VEG FR3 (white), and αSMA (red). Arrowhead indicates artery; arrow indicates vein. E15.5, n = 6. Scale bar, 
50 µm. (B) Lymphatic remodeling during iLN development. Whole mount and frontal views (10 µm): PROX1 (red) and CD4 (green). E15.5, n = 4; E16.5, n = 5; 
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Zheng et al. (2014), the treatment severely diminished dermal 
lymphatics (Fig.  3  I). However, prominent, albeit reduced LTi 
cell accumulation was still observed in LN anlagen in the ab-
sence of associated lymphatic vessels (Fig. 3 I; LN volume, 103 
µm3; control IgG, 319.2 ± 115.9; VEG FR3-blocking IgG, 79.2 ± 25.5; 
P = 0.0272). Furthermore, we readily visualized LTi cells in SMC-
low gaps in the vein in both control and VEG FR3 IgG-treated em-
bryos (Fig. 3 I′).
We next monitored the global distribution of CD4+ LTi cells in 
the embryonic skin. We observed CD4+ cells associated with the 
upper dermis blood vascular plexus (Fig. 3, J and J′). Isolated CD4+ 
cells and clusters were frequently present in the lymphatic plexus 
at E15.5 and later in lymphatic capillaries and in afferent and ef-
ferent LN collecting vessels (Fig. 3, K and L; and Fig. S2, A–D). A 
similar distribution of GFP+ cells was observed in Rorc(γt)EGFP/+ 
embryos (Fig. S2, E–G). Our data corroborate lymphatic vessel–
independent LN initiation model also for the iLN (Vondenhoff et 
al., 2009b). However, in agreement with Onder et al. (2017), they 
show that a reservoir of disseminated LTi cells critically contrib-
utes to LN expansion. These results unify the previous models 
and further suggest that the SMC coverage in part defines the site 
and the time of pre-LTi cell egress from veins.
Efficient LTi cell uptake and transport to the LN anlagen 
requires CCR7 signaling
Following VEG FR3 blockade, we sometimes observed isolated 
LEC spheroids (Fig.  4  A), likely formed by nonvenous dermal 
LEC progenitors (Martinez-Corral et al., 2015). The LEC spher-
oids contained CD4+ cells (Fig. 4 B), indicating that even discon-
nected LECs attract LTi cells. In adults, CCR7 drives migration of 
DCs and T cells toward and inside of CCL21+ initial lymphatics 
(Ohl et al., 2004; Bromley et al., 2005; Debes et al., 2005; Russo 
et al., 2016). Because LTi cells express functional CCR7 (Honda et 
al., 2001), we analyzed iLN development in Ccr7−/− mice. While 
the lymphatic vascular development was not affected (Fig. S2, 
H and I), Ccr7−/− iLNs were smaller, and we observed almost no 
intralymphatic LTi cell clusters (Fig. 4, C–E). Meanwhile, the ex-
travascular CD4+ LTi cell fraction was increased (Fig. 4 F). There-
fore, in addition to the role of CCL21 in LTi cell retention at LN site 
(Onder et al., 2017), CCL21+ initial lymphatics attract and collect 
disseminated LTi cells.
Loss of CXCR5 leads to tissue and intralymphatic 
accumulation of LTi cells
In addition to CD4+ cells in lymphatic capillaries and afferent LN 
lymphatics, we observed a low but significant number of CD4+ 
cells in iLN efferent vessels (Fig. S2, A and D). The dynamic equi-
librium between arriving, retained, and departing LTi cells thus 
defines the iLN size. To study whether defective retention of 
LTi cells shifts the balance toward LTi cell accumulation in lym-
phatic vessels, we analyzed Cxcr5−/− embryos. Loss of CXCR5+ LTi 
cell attraction by CXCL13+ LTo cells prevents formation of most 
peripheral LNs, including iLN (Förster et al., 1996; Ansel et al., 
2000; Ohl et al., 2003; Fig. 4, G, G′, and H). Lymphatic vessels at 
the presumptive Cxcr5−/− iLN site did not develop the character-
istic lymphatic cup found in WT mice but maintained a collect-
ing vessel phenotype (Fig. 4, G and G′). As in Cxcr5−/− animals, 
lymphatic vessel remodeling into a LN capsule was abolished in 
LTb−/− embryos (Koni et al., 1997), which do not form peripheral 
LNs due to lack of surface LTβ presentation (Fig. S2, J and K), 
further confirming the driving role of LN anlagen in LN capsule 
and SCS development. Strikingly, lymphatic vessels of Cxcr5−/− 
mice were filled with intralymphatic CD4+ clusters (Fig. 4 I and 
Fig. S2 L). Such clusters were biggest at the presumptive iLN site, 
but smaller clusters were also disseminated throughout the lym-
phatic vascular network (Fig. 4 I). Furthermore, the number of 
isolated CD4+ cell in the skin interstitium was increased (Fig. 4 J). 
Our results thus show that extravascular LTi cell accumulation is 
a prerequisite for the induction of lymphatic vessel remodeling 
and LN capsule formation.
SCS specialization occurs prenatally and coincides with 
lymphatic vascular maturation
Acquisition of a capillary or collecting phenotype is a key step 
of lymphatic vascular development. In skin, this process starts 
at E15.5–E16.5 and thus coincides with initiation of iLN capsule 
formation. We studied whether all LECs of the LN lymphatic cup 
belong to one or another vessel type by staining for collecting or 
capillary markers FOXC2 or LYVE1 (Schulte-Merker et al., 2011). 
The LECs of the outer layer expressed high levels of FOXC2, 
whereas LECs in the inner layer were FOXC2− but produced 
higher levels of LYVE1 (Fig. 5 A), indicating a hybrid collecting–
capillary identity of the prenatal SCS.
Such organization is reminiscent of adult LN SCS, which con-
tains distinct populations of ceiling LECs (cLECs) and floor LECs 
(fLECs). Only cLECs produce the chemokine receptor CCRL1, 
while fLECs express LYVE1, ITGA2B, and MadCAM1 (Cohen 
et al., 2010; Ulvmar et al., 2014; Cordeiro et al., 2016). In adult 
LNs of Ccrl1-EGFP mice, FOXC2 was coexpressed with CCRL1 
in cLECs (Fig. S3, A and A′), confirming conservation of asym-
metric FOXC2 localization within the SCS. In embryonic iLNs, 
the inner LECs expressed fLEC-specific ITGA2B and MadCAM1, 
whereas a subset of outer LECs produced CCRL1 (Fig. 5, B–D). 
We observed continuous CCRL1 expression in cLECs in axillary 
LN, more advanced in its development (Fig. 5 D; Rennert et al., 
1996). The VEG FR3+ collagen IV+ LECs interconnected the cLEC 
and fLEC layers (Fig.  5  E). Such pillars were LN specific and 
were absent in all other lymphatic vessels examined. They likely 
E18.5–E19.0, n = 6; E20.0, n = 3. Scale bar, 50 µm. (C) Peripheral but not LN LECs express NRP2. Whole mount skin: NRP2 (white), PROX1 (red), and CD4 (green). 
E15.5, n = 4. Scale bar, 50 µm. (D) LECs at the LN sprouting edge express NRP2. Whole mount and frontal view (10 µm): NRP2 (white), PROX1 (red), and CD4 
(green). Arrowheads indicate NRP2+ LECs. E16.5, n = 6. Scale bar, 50 µm. (E) LN LECs actively proliferate. Whole mount views in the top (20 µm) and middle 
(5 µm) iLN areas: CD4 (green), PROX1 (blue), and EdU (red). E18.5, n = 4. Scale bar, 80 µm. (E′) High-magnification view of the yellow box in E. A mask was 
applied to identify EdU+ PROX1+ cells (red). Dotted line indicates PROX1+ EdU+ nuclei. Scale bar, 20 µm. (F) Quantification of EdU+ LECs in the top and middle 
parts of the LN cup. E18.5, n = 4. Two-tailed unpaired Student’s t test; *, P < 0.05. Data are shown as mean ± SD. (G) LEC sprouting versus LN engulfment. All 
peripheral LECs express NRP2 (NRP2high), but only few LECs at the borders of converging double-walled LN LEC layer are NRP2+.
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represent sinus-traversing strands of adult LN SCS (Ohtani et 
al., 2003; Rantakari et al., 2015) and may be preventing the SCS 
lumen collapse, in addition to their role in filtering the afferent 
lymph. Finally, the CD169+ macrophages inserted into the adult 
SCS fLEC layer prevent dissemination of pathogens and deliver 
antigens to adjacent B cells (Carrasco and Batista, 2007; Junt et 
al., 2007; Phan et al., 2007). Surprisingly, we observed CD169+ 
macrophages within the fLEC layer already at E18.5 (Fig. 5 F). 
Taken together, our data show that specialization of SCS LECs is 
established prenatally, and this timing coincides with initiation 
of collecting lymphatic vessel maturation.
Disruption of collecting vessel specialization prevents LN 
capsule and SCS formation
We asked next whether disruption of collecting vessel special-
ization affects LN development. In Foxc2−/− mice, primary lym-
phatic capillary plexus fails to remodel into collecting vessels 
(Petrova et al., 2004; Norrmén et al., 2009). We analyzed LN 
development in Foxc2f/f; Prox1-CreERT2 (Foxc2lecKO) mice with 
LEC-specific loss of FOXC2. As described earlier (Sabine et al., 
2015), Foxc2lecKO embryos had a complete arrest of collecting 
vessel development, as determined by the absence of valves and 
expression of capillary markers LYVE1 and CCL21 in all LECs 
(Fig. 6 A and Fig. S3 B). In parallel with the failed collecting vessel 
maturation, formation of the LN capsule was severely disrupted: 
instead of a continuous lymphatic cup, Foxc2lecKO iLN anlage was 
surrounded by a mesh-like vasculature, only partially enclosing 
the LN (Fig. 6 B).
The LN LECs in Foxc2lecKO mice failed to express SCS LEC 
markers ITGA2B or CCRL1, whereas LYVE1 and MAdCAM1 were 
uniformly high. Moreover, mislocalized SMCs encircled the LN 
lymphatic vessels (Fig. 6, C–F′). Furthermore, while CD169+ mac-
rophages were aligned with fLECs in the WT iLN, in Foxc2lecKO 
mice the number of macrophages was reduced, and they were 
dispersed throughout the LN (Fig. 6 G). These results demon-
strate that FOXC2 ensures both collecting vessel maturation and 
prenatal LN LEC capsule specialization.
Impaired LN expansion, lymphatic trafficking of LTi cells, and 
CXCL13 expression in Foxc2lecKO mice
From E18.5 onward, the Foxc2lecKO iLNs were significantly smaller 
than controls (Fig. 7 A). Organization of axillary and mesenteric 
LNs was also perturbed, but the formation of nonencapsulated 
Peyer’s patches was not affected (Fig. 7, B–F). We next investigated 
the reason for the reduced Foxc2lecKO LN size. The LTi cells in both 
E18.5 control and Foxc2lecKO animals were mostly quiescent, and 
staining for activated caspase 3 did not reveal differences in cell 
death (Fig. S3, C–E). Instead, we observed accumulation of intra- 
and extravascular CD4+ cells and large intralymphatic clusters 
both in the vicinity of LN anlagen and throughout the dermal and 
mesenteric lymphatic vessels of Foxc2lecKO mice (Fig. 7, G–K; and 
Fig. S3 F). These results demonstrate that collecting vessel mat-
Figure 2. SMC recruitment and deposition of basement membrane during LN capsule formation. (A) SMCs surround iLN. Whole mount: αSMA (red) and 
CD4 (green). Arrowheads indicate LN SMCs. E18.5, n = 3. Scale bar, 50 µm. (A′) Transverse and frontal views (1 µm) of A, LYVE1 (white). Scale bar, 50 µm. (B) 
Extracellular matrix deposition around iLN. Whole mount 10-µm transverse view: collagen IV (red), PROX1 (blue), and CD4 (green). High-magnification image 
is shown on the right. E18.5, n = 3. Scale bars, 50 µm and 30 µm. (C) LN LECs in contact with SMCs express PDGFβ. Whole mount of iLN from Pdgfβ-CreERT2-
IRES-EGFP mice (1 µm): GFP (green), αSMA (red), and LYVE1 (blue). High-magnification images are shown at the bottom. Dotted line indicates PDGFβ+ LYVE1+ 
LECs. E18.5, n = 5. Scale bars, 100 µm and 20 µm. (D) LN capsule expansion steps. Artery and blood capillaries inside the LN are not shown.
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Figure 3. Blood and lymphatic vessels contribute to early LN development. (A) Skin areas analyzed. 1, axillary area; 2, inguinal area. (B) Laminin α5 is not 
produced by veins at E15.0. Whole mount: endomucin (green) and laminin α5 (red). v, vein; a, artery. Arrowheads indicate vein. E15.0, n = 4; E16.5, n = 3. Scale 
bar, 50 µm. (C) Differential venous SMC coverage in axillary versus inguinal areas at E15.0 but not at E18.5. Whole mount: αSMA (red) and laminin α5 (green). v, 
vein; a, artery. Arrowheads indicate SMC gaps on the vein. Scale bar, 50 µm. E15.0, n = 5; E18.5, n = 3. (D) Low venous SMC coverage in E15.0 iLN region. Whole 
mount: CD4 (green), αSMA (red), and endomucin (white). Arrowheads indicate SMC-low gaps. E15.0, n = 3. Scale bar, 50 µm. (E) Quantification of venous SMC 
coverage in iLN versus axillary area. E15.0, n = 3. *, P < 0.05. (F) LTi cells in αSMA-low areas. Whole mount of subepigastric vein (1 µm): CD4 (green), αSMA (red), 
and endomucin (white). (F′) High magnification of F. Arrowhead indicates LTi cell in SMC-low space. E15.0, n = 3. Scale bars, 20 µm and 15 µm. (G) Increased LN 
size in Pdgfbret/ret embryos. Whole mount iLN (1 µm): CD4 (green), endomucin (white), and αSMA (red). Scale bar, 50 µm. (H) Quantification of E17.5 Pdgfbret/+ 
and Pdgfbret/ret iLN volume. Pdgfbret/+, n = 3; Pdgfbret/ret, n = 4. *, P < 0.05. (I) iLN anlagen of embryos treated with control or VEG FR3-blocking antibody. Whole 
mount iLN: VEG FR3 (green), αSMA (red), and CD4 (white). E15.5, n = 4 per treatment. Scale bar, 50 µm. (I′) High-magnification view of I (1 µm). Arrowheads 
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uration is essential for LN capsule formation, SCS specialization, 
and further LN expansion.
Because of intralymphatic accumulation of LTi cell clusters in 
both Cxcr5−/− and Foxc2lecKO mice, we compared the expression of 
CXCR5 ligand Cxcl13 as well as of Ccl21 and Ccl19 chemokines in 
Foxc2lecKO or WT iLNs. WT iLNs produced more Cxcl13, Ccl21, and 
Ccl19 mRNA in comparison to the skin, and only Cxcl13 mRNA 
was significantly decreased in the absence of FOXC2 (Fig. 8, A 
and B). On the protein level, CXCL13 but not VCAM1, ICAM1, and 
RAN KL was reduced in Foxc2lecKO iLNs (Fig. 8, C–J). Because lower 
CXCL13 could be a result of reduced LTi cell number in Foxc2lecKO 
iLNs, we quantified CXCL13 and VCAM1 levels in E17.5 WT and 
E18.5 Foxc2lecKO iLNs, which have similar sizes (Fig. 8 K). Only 
CXCL13 but not VCAM1 was decreased in E17.5 Foxc2lecKO iLNs 
(Fig. 8, L–O), demonstrating that LTi cell number is not a criti-
cal parameter at this stage. These results show that lymphatic 
vessel specialization is important for stromal CXCL13 expression 
and LN expansion.
Interstitial fluid flow (IFF) potentiates production of 
Cxcl13 by fibroblasts
LTβR signaling promotes CXCL13 expression by fibroblastic 
LTo cells (Rennert et al., 1998; Dejardin et al., 2002; Müller and 
Siebenlist, 2003). However, LTβR, LTβ, or LTα expression was not 
affected in Foxc2lecKO iLNs (Fig. 8 B). We then reasoned that LTβR 
signaling, supplied by LTαβ+ LTi cells (Vondenhoff et al., 2009a), 
may be necessary but not sufficient to fully activate Cxcl13 ex-
pression in LTo cells.
To clarify the mechanism of Cxcl13 down-regulation in the 
Foxc2lecKO iLNs, we first asked whether LECs enhance CXCL13 
production by LTo cells. We cultured mouse embryonic fibro-
blasts (MEFs) with LN LECs or LN LEC–conditioned medium in 
the presence or in the absence of LTβR-activating antibody (Fig. 
S4, A–C). As expected (Dejardin et al., 2002; Müller and Siebenlist, 
2003), LTβR activation induced Cxcl13 and Vcam1 in MEFs (Fig. 
S4 C). However, co-culture with LECs or with LEC-conditioned 
medium suppressed the induction of Cxcl13 (Fig. S4 C). Thus, 
direct contact with LECs is unlikely to induce Cxcl13 in LTo cells.
By absorbing plasma leaking from blood capillaries, lymphatic 
vessels generate IFF, which has important morphogenetic func-
tions (Starling, 1896; Wiig and Swartz, 2012). We reasoned that 
engulfment of LN anlagen by growing LN capsule creates high 
IFF, from the moment when embryonic maturing lymphatics ini-
tiate directional lymph transport. To analyze whether IFF affects 
Cxcl13 expression in vitro, we cultured MEFs in three dimensions 
in the presence or absence of LTβR-activating antibody in static 
or IFF conditions (Fig. 9 A). As expected (Chambliss et al., 2013), 
IFF induced formation of actin stress fibers indicating cytoskel-
eton reorganization (Fig. 9 B). Most importantly, IFF potentiated 
the production of Cxcl13 mRNA in response to LTβR activation 
(Fig. 9 C). To study IFF in vivo, we microinjected FITC-dextran in 
the forelimb interstitium of E18.5 control or Foxc2lecKO embryos. 
WT lymphatic vessels readily drained the dye, but transport into 
lymphatic vessels of Foxc2lecKO mice was strongly reduced (Fig. 9, 
D and E). We suggest that in addition to their role in LTi cell trans-
port, perinodal lymphatics promote IFF, which cooperates with 
LTβR signaling to induce CXCL13 in fibroblastic LTo cells and 
thereby enhances LTi cell retention in the LN anlage (Fig. 10).
Discussion
We report a high-resolution analysis of coordinated changes 
occurring during lymphatic vessel and LN development. Our 
results clarify blood and lymphatic vessel contribution to LN 
initiation and expansion, describe the process of LN capsule and 
SCS formation, and reveal the key role of collecting lymphatic 
vessels and their transport function in LN development.
Blood and lymphatic vessels in LN initiation and expansion
Together with the results of Vondenhoff et al. (2009b), our data 
show that initiation of LNs occurs independently of lymphatic 
vessels. We propose that similar to leukocyte extravasation in 
inflammation, CD4− pre-LTi cells initially egress in specific ve-
nous locations with low SMC coverage, thus defining positioning 
of the future LN, and undergo local maturation into CD4+ LTi 
cells. Embryos with reduced SMC coverage develop larger LNs, 
indicating that immature blood vessels are a prerequisite for LTi 
cell entry into the future LN area. In agreement with Onder et 
al. (2017), we also show that lymphatic vessels transport the dis-
seminated LTi cells and thus play a critical role in the expansion 
of early LNs. Our results unify the previous views and further 
suggest that venous SMC coverage status in part defines the site 
and the time of pre-LTi cell egress. Our static imaging approach 
has limitations: it remains possible that the observed venous 
trafficking of LTi cells in iLN anlage represents the reverse mi-
gration into blood vessels. However, we found only CD4− RORγt+ 
intravenous LTi cells in the iLN area, which is in agreement 
with previous work (Mebius et al., 1997) that postulated the ex-
istence of extravascular maturation of LTi cells. Live imaging 
and characterization of extravascular versus intravascular LTi 
cells will be invaluable for further unraveling this fascinating 
process. Because development of different LNs is guided by dis-
tinct kinetics, similar high-resolution studies should also be ex-
tended to other LNs.
A lymphatic engulfment model for LN formation
Lymphatic vessels undergo striking remodeling during LN 
development. Similar to other lymphatic vascular beds, this 
process is VEG FC/VEG FR3-dependent (Lee and Koh, 2016; 
this study), but it differs from sprouting lymphangiogenesis 
indicate LTi cells in SMC-low gaps of the vein at iLN site. Scale bar, 20 µm. (J) LTi cells in blood capillaries. Whole mount skin: CD4 (green), collagen IV (red), 
and PEC AM1 (white). E15.0, n = 4. Scale bar, 50 µm. (J′) High-magnification view of J (1 µm). Scale bar, 15 µm. (K) LTi cells in lymphatic capillaries. Whole mount 
skin: VEG FR3 (green), αSMA (red), and CD4 (white). Arrowhead indicates intralymphatic LTi cell. E15.5, n = 4. Scale bar, 70 µm. (K′) High magnification of 1-µm 
transverse (top) and frontal (bottom) views of the area outlined in K. Scale bar, 10 µm. (L) LTi cells in collecting vessels. Whole mount of skin: VEG FR3 (green), 
αSMA (red), and CD4 (white). E15.5, n = 4. Scale bar, 70 µm. (L′) High magnification of L (1 µm). Arrowhead indicates intralymphatic LTi cell. Scale bar, 10 µm. 
Data are shown as mean ± SD. All quantifications use two-tailed unpaired Student’s t test.
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observed in peripheral lymphatics. The canonical lymphan-
giogenic response includes selection of tip cells, sprouting in 
response to a VEG FC gradient, followed by proliferation of stalk 
cells, which establish a vascular lumen and partially anasto-
mose to form a mesh-like lymphatic vasculature (Ulvmar and 
Mäkinen, 2016). In contrast, collective migration and prolifer-
ation of LN LECs lead to formation of a double-walled cup-like 
structure, engulfing the developing LN, with only rare sprout-
ing LECs observed at the top of converging EC sheets (Fig. 1 G). 
Why VEG FC induces LN engulfment rather than a sprouting 
response remains to be investigated. This could be due to the 
uniformly high production of VEG FC in LN cells, resulting in 
the absence of VEG FC gradient. Indeed, LTo cells express high 
VEG FC levels (Okuda et al., 2007), while LN LECs produce only 
low levels of the guidance molecule NRP2 that promotes VEG 
FC-driven LEC sprouting (Xu et al., 2010). Our results reveal 
the diversity of organ-specific mechanisms of lymphatic vessel 
expansion and highlight the need to further investigate the un-
derlying mechanisms.
An advantage of LN engulfment versus lymphangiogenic 
sprouting is the maintenance of overall vessel integrity and 
transport function throughout the remodeling process, which is 
critical for bringing in the disseminated LTi cells. We also show 
that CCR7+ LTi cells use CCL21+ lymphatic capillaries as a direct 
route toward the LNs. However, albeit reduced in number, most 
LNs are present in mice lacking CCR7 or its ligands (Förster et al., 
1999; Luther et al., 2003), indicating that additional mechanisms 
controlling lymphatic trafficking of LTi cells should exist.
Figure 4. Embryonic lymphatics transport LTi cells. (A) LEC spheroids in embryos treated with VEG FR3-blocking antibody. Whole mount skin: VEG FR3 
(green) and αSMA (red). Arrowheads indicate LEC spheroids. E15.5, n = 6 per treatment condition. Scale bar, 200 µm. (B) LTi cells in LEC spheroids. Whole 
mount skin: VEG FR3 (green), DAPI (blue), and CD4 (white). Arrowheads indicate intralymphatic LTi cells. E15.5, n = 6. Scale bar, 50 µm. (C) Smaller iLNs in 
Ccr7−/− embryos. Whole mount iLN: VEG FR3 (red) and CD4 (green). E18.5, n = 3 per genotype. Scale bar, 50 µm. (D) Quantification of iLN size in WT and Ccr7−/− 
embryos. E18.5, n = 3 per genotype; *, P < 0.05. (E) Quantification of intralymphatic CD4+ clusters. E18.5, n = 6 per genotype; *, P < 0.05. (F) Percentage of 
extravascular CD4+ cells in WT and Ccr7−/− skin. E18.5, n = 6 per genotype; *, P < 0.05. (G) Absence of cup-like lymphatic structures in Cxcr5−/− embryos. Whole 
mount iLN: VEG FR3 (red) and CD4 (green). (G′) 10-µm frontal section. Arrowhead indicates lymphatic valve. E19.0, n = 3 per genotype. Scale bar, 50 µm. (H) 
CD4+ inguinal cluster size in WT and Cxcr5−/− mice. E19.0, n = 4 per genotype; *, P < 0.05. (I) Quantification of intralymphatic CD4+ clusters in WT and Cxcr5−/− 
E19.0 skin. WT, n = 3; Cxcr5−/−, n = 4; *, P < 0.05. (J) Quantification of isolated CD4+ cells in WT and Cxcr5−/− E19.0 skin. n = 3 per genotype; *, P < 0.05. Data 
are shown as mean ± SD. All quantifications use two-tailed unpaired Student’s t test.
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LN SCS specialization and LN expansion are linked to collecting 
vessel formation
The adult LN SCS is lined by specialized LECs, which ensures op-
timal immune responses. The specification of SCS LECs occurs 
before birth and is characterized by acquisition of polarized ex-
pression of cLEC and fLEC markers CCRL1, ITGA2B, MAD CAM1, 
and LYVE1; formation of transversal SCS LEC strands; recruitment 
of CD169+ macrophages; and LN capsule SMCs (Fig. 5; Cordeiro et 
al., 2016). Thus, all cues for the differentiation of cLECs/fLECs and 
for positioning of specialized LN cells are present before birth. 
Importantly, we found that SCS specialization coincides with for-
mation of collecting lymphatic vessels. By analyzing Foxc2lecKO 
embryos with defective collecting vessel morphogenesis we show 
that LN and collecting vessel development are highly coordinated, 
and disruption of collecting vessel function prevents formation 
of the LN capsule and SCS LEC specialization.
Figure 5. Prenatal SCS LEC specification coincides with lymphatic vascular maturation. (A) Collecting and capillary LEC markers in iLN lymphatics. Whole 
mount iLN (5-µm transverse section): FOXC2 (green), PROX1 (red), and LYVE1 (white). Arrowheads indicate PROX1+/FOXC2+ LECs. High-magnification images 
are shown on the right. E20.5, n = 1. The same expression pattern was observed at E16.5 (n = 3) and E18.5 (n = 1). Scale bars, 50 µm and 20 µm. (B) Staining 
of iLN for ITGA2B (green) and LYVE1 (red). High-magnification images are shown at the bottom. Arrowheads indicate ITGA2B+ LECs; arrows indicate blood. 
E18.5, n = 3. Scale bars, 50 µm and 15 µm. (C) Staining of axLN for MAD CAM1 (red) and LYVE1 (green). High-magnification images are shown at the bottom. 
Arrowheads indicate MAD CAM1+ LECs. E18.5–E20.5, n = 5. Scale bars, 50 µm and 20 µm. (D) Staining of E20.5 inguinal (iLN) and axillary (axLN) for CCRL1 
(red), PROX1 (white), and LYVE1 (green). axLN, n = 4; iLN, n = 3. Scale bar, 50 µm. (E) LEC pillars connect two LN capsule layers. Whole mount (5-µm transverse 
section): collagen IV (white), VEG FR3 (red), and CD4 (green). E19.0, n = 3. Scale bar, 50 µm. (F) CD169+ macrophages in the iLN SCS. Staining for CD169 (red), 
LYVE1 (white), and DAPI (blue). High-magnification image is shown on the right. E18.5–E20.5 iLN, n = 4. Scale bars, 50 µm and 5 µm.
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Role of biomechanical forces in LN development
CXCL13/CXCR5 signaling is indispensable for LTi cell retention 
within the LN anlagen and LN development (van de Pavert and 
Mebius, 2010). We show now that in Cxcr5−/− embryos, LTi cells 
are widely disseminated in the tissues and in the lymphatic vas-
culature. Foxc2lecKO embryos display a similar phenotype indicat-
ing that functional collecting vessels participate in the regulation 
of CXCL13. Indeed, CXCL13 is selectively reduced in LTo cells of 
Foxc2lecKO mice. Surprisingly, we found that the interstitial flow 
potentiates Cxcl13 expression by LTβR-activated MEFs, and such 
flow is impaired in Foxc2lecKO mice, indicating that lymphatic 
vessel transport function and IFF contribute to LN expansion. 
The expression of CCL21, induced by IFF in adult LN (Tomei et 
al., 2009), was not affected, suggesting a differential responsive-
ness of embryonic versus adult stromal cells. Primary cilia sense 
IFF (Nag and Resnick, 2017); however, loss of cilia did not affect 
IFF-dependent Cxcl13 production by MEFs, indicating that alter-
native mechanisms are involved (unpublished data). How LTo 
cells sense IFF and how this process potentiates LTβR signaling 
at the molecular level will require more work. Most importantly, 
Figure 6. Impaired collecting vessel development disrupts LN LEC specification and capsule formation. (A) Increased LEC capillary markers in Foxc2lecKO 
mice. Whole mount skin: CCL21 (red) and LYVE1 (white). Scale bar, 100 µm. E18.5, n = 2 per genotype. Similar expression pattern was observed at E20.5 (WT, 
n = 1; Foxc2lecKO, n = 3). (B) Impaired LN capsule organization in Foxc2lecKO embryos. Whole mount iLN area: CD4 (green) and VEG FR3 (red). Arrowhead indi-
cates mesh-like lymphatic capsule. E19.0, n = 3 per genotype. Scale bar, 50 µm. (C) Loss of fLEC ITGA2B expression in Foxc2lecKO mice. Staining of E18.5 iLN for 
ITGA2B (green) and LYVE1 (red). High-magnification images are shown at the bottom. White arrowhead indicates cLECs; yellow arrowhead indicates fLECs; 
pink arrowheads indicate Foxc2lecKO unspecified LECs. WT, n = 3; Foxc2lecKO, n = 5. Scale bars, 50 µm and 20 µm. (D) Reduced CCRL1 expression in Foxc2lecKO 
LN. Staining of E20.5 axillary LN for LYVE1 (green), CCRL1 (red), PROX1 (white), and DAPI (blue). High-magnification images are shown at the bottom. White 
arrowhead indicates LYVE1low CCRL1high LECs; yellow arrowheads indicate LYVE1high CCRL1neg LECs. WT, n = 4; Foxc2lecKO, n = 3. Scale bars, 50 µm and 10 µm. 
(E) Loss of polarized MAD CAM1 in iLN LECs of Foxc2lecKO mice. Staining for LYVE1 (green), MAD CAM1 (red), and DAPI (blue). High-magnification images are 
shown at the bottom. White arrowhead indicates LYVE1low MAD CAMneg LECs; yellow arrowheads indicate LYVE1high MAD CAMhigh LECs. E18.5–E20.5 WT, n = 
4; Foxc2lecKO, n = 3. Scale bars, 50 µm and 25 µm. (F) Mislocalized SMC coverage on Foxc2lecKO iLN lymphatics. Whole mount iLN (10 µm): CD4 (green), αSMA 
(red), and LYVE1 (white). (F′) Transverse (top) and frontal (bottom) views (10 µm) of F. Arrowheads indicate ectopic SMCs. E18.5 WT, n = 3; Foxc2lecKO, n = 4. 
Scale bar, 50 µm. (G) Reduced number and mislocalization of CD169+ macrophages in Foxc2lecKO mice. Whole mount iLN: CD169 (white) and DAPI (blue). 10-µm 
frontal views are shown at the bottom. Arrowheads indicate CD169+ macrophages. E18.5–E19.0 WT, n = 5; Foxc2lecKO, n = 4. Scale bar, 70 µm.
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these results identify a new role of mechanical forces in LN devel-
opment and suggest that IFF, generated by perinodal lymphatic 
vessels, enhances the efficiency of LTβR signaling between LTi 
and LTo cells and thus contributes to LN expansion.
In summary, our work reveals multiple roles of lymphatic ves-
sels in LN development. While the initial LTi cell egress occurs from 
blood vessels, lymphatic vessels also participate in the LTi cell trans-
port to LN anlagen. Around the LN anlage, collecting vessels reor-
ganize into a capsule to further increase the efficiency of LTi cell 
delivery and retention. We further propose a novel role of IFF gen-
erated by perinodal lymphatics for potentiating CXCL13 expression 
by fibroblastic LTo cells in response to simultaneous LTβR signaling.
Figure 7. Impaired LN expansion and trafficking of LTi cells in Foxc2lecKO mice. (A) iLN size in WT and Foxc2lecKO embryos. E16.5, n = 4 and 3; E18.5–E19.0, 
n = 9 and 12; E20.0, n = 3 and 3 for WT and Foxc2lecKO genotypes, respectively. *, P < 0.05. (B) Impaired axillary LN development in E20.5 Foxc2lecKO embryos. 
Staining for LYVE1 (green), PROX1 (red), and CD4 (white). Asterisk indicates swollen LN lymphatics in Foxc2lecKO mice. n = 2 per genotype. Scale bar, 100 µm. 
(C) Impaired mesenteric LN development in E18.5 Foxc2lecKO embryos. Staining for CD4 (green) and PROX1 (white), 10-µm transverse sections. n = 4 per 
genotype. Scale bar, 200 µm. (D) Normal development of Peyer’s patches (PPs) in E19.0 Foxc2lecKO embryos. Whole mount staining for CD4 (green) and LYVE1 
(red). Arrowheads indicate sprouting LECs. WT, n = 4; Foxc2lecKO, n = 3. Scale bar, 50 µm. (E) Quantification of E18.5 PP size. WT, n = 6; Foxc2lecKO, n = 4. (F) 
Quantification of E18.5 PP number. WT, n = 9; Foxc2lecKO, n = 5. (G) Increased isolated CD4+ LTi cells in Foxc2lecKO dermis and lymphatic vessels. Whole mount 
E18.5 skin: CD4 (green) and PROX1 (red). Pink arrowheads indicate intralymphatic CD4 cells; white arrowheads indicate extravascular CD4 cells. WT, n = 3; 
Foxc2lecKO, n = 4. Scale bar, 50 µm. (H) Quantification of isolated extralymphatic and intralymphatic CD4+ cells in E18.5–E19.0 WT and Foxc2lecKO embryos. WT, 
n = 6; Foxc2lecKO, n = 7. *, P < 0.05. (I) Intralymphatic CD4+ clusters in skin of Foxc2lecKO embryo. Whole mount staining for CD4 (green) and PROX1 (red). E19.0 
WT, n = 3; Foxc2lecKO, n = 4. Scale bar, 50 µm. (J) Quantification of intralymphatic CD4+ clusters in skin of E18.5–19.0 WT (n = 9) and Foxc2lecKO (n = 10) mice. *, 
P < 0.05. (K) CD4+ intralymphatic cluster size in E18.5–E19.0 skin of WT (n = 9) or Foxc2lecKO (n = 10) embryos. *, P < 0.05. ns, not significant. Data are shown 
as mean ± SD. All quantifications use two-tailed unpaired Student’s t test.
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Figure 8. Reduced Cxcl13 in iLN of Foxc2lecKO mice. (A and B) Confirmation of Foxc2 deletion at E18.5 in Foxc2lecKO model (A) and Cxcl13 mRNA selective 
reduction in E18.5 Foxc2lecKO iLNs (B). RT-qPCR for the indicated genes in iLNs and skins. WT, n = 3–6; Foxc2lecKO, n = 2–5. *, P < 0.05. (C) Comparable VCAM1 
levels in E18.5 WT and Foxc2lecKO embryos. Whole mount iLN (5 µm) for CD4 (green), VCAM1 (red), and LYVE1 (white). E18.5 WT, n = 3; Foxc2lecKO, n = 4. Scale 
bar, 50 µm. (D) Quantification of VCAM1 intensity. E18.5 WT, n = 3; Foxc2lecKO, n = 4. (E) Comparable levels of ICAM1 in WT and Foxc2lecKO iLNs: CD4 (green), 
ICAM1 (red), and LYVE1 (white). E18.5–E20.5, n = 4 per genotype. Scale bar, 50 µm. (F) Quantification of ICAM1 intensity. E18.5–E20.5, n = 4 per genotype. 
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Animal experiments were approved by the Animal Ethics Com-
mittee of Canton of Vaud, Switzerland; by the Animal Experi-
mentation Committee of the county of Münster, Germany; and 
by the Animal Experimentation Committee of Uppsala, Swe-
den. Foxc2fl/fl (Sabine et al., 2015), Prox1-CreERT2 (Bazigou et al., 
2011), Cxcr5−/− (Förster et al., 1996), Ltb−/− (Koni et al., 1997), 
Ccr7−/− (Förster et al., 1999), Pdgfbret (Lindblom et al., 2003), 
Id2-CreERT2 (Rawlins et al., 2009), Rorc(γt)EGFP/+ (Eberl et al., 
2004), Ccrl1-eGFP (Heinzel et al., 2007), and Pdgfβ-CreERT2-
IRES-EGFP (Claxton et al., 2008) were previously described. 
All mice were bred to at least the sixth generation on C57BL6/J 
background. For embryo experiments, matings were set up in 
the evening, and plugs were verified in the morning. Embryonic 
age (E) was determined according to the day of the vaginal plug 
(E0.5). For conditional gene inactivation, pregnant mice were 
injected with 5 mg of tamoxifen and 5 mg of progesterone in 
100 µl sunflower seed oil between E13.5 and E14.5. When indi-
cated, 5 µg/g EdU (Life Technologies) was injected i.p. 1 h before 
sacrifice. To block lymphangiogenesis, C57BL6/J pregnant mice 
were injected i.p. at E11.5 and E13.5 with 30 mg/kg rat anti-VEG 
FR3 (Pytowski et al., 2005) or control rat anti-HRPN IgG anti-
bodies (BioXCell).
Microlymphangiography
Embryos were injected with 0.5–1  µl of 10 mg/ml 2,000-kD 
FITC-dextran (Sigma-Aldrich) into the interstitium of forelimb 
foot pads using a 10-µl Hamilton syringe. Lymphatic drainage 
was analyzed using Leica M205 FA stereomicroscope, Leica DFC 
3000 G camera, and LAS X software.
Mouse tissue collection, staining procedures, and 
image acquisition
For whole mount staining, tissues were fixed with 4% parafor-
maldehyde (PFA), washed with PBS, permeabilized with 0.5% 
Triton X-100, and blocked with 5% donkey serum. Tissues were 
incubated with primary followed by secondary antibodies for 3 
d on a rotating platform at 4°C and cleared using 3DIS CO pro-
tocol (Ertürk et al., 2012) or alternatively incubated overnight 
with Histodenz (Sigma) at room temperature. 8-µm cryosec-
tions were 4% PFA–fixed, washed with PBS, permeabilized with 
0.5% Triton-X-100, and blocked with 5% donkey serum. 5-µm 
deparaffinized tissue sections were subjected to heat-induced 
epitope retrieval (High pH Retrieval solution; DAKO). Click-it 
EdU Alexa Fluor 555 kit (Life Technologies) was used for EdU 
detection. For staining of cultured MEFs, cells were fixed with 
4% PFA, washed with PBS, permeabilized with 0.1% Triton X-
100, and blocked with 5% donkey serum. Alexa 488–conjugated 
phalloidin (Life Technologies) and DAPI (Sigma) were added to 
the chips overnight. Images were taken using confocal Zeiss LSM 
880 or Leica SP5 Tandem microscopes and analyzed using Imaris 
and Adobe Photoshop software. Frontal stacks of whole mount 
images were on average 10 µm thick, and transverse stacks were 
5–10 µm thick. Large image tiles were acquired using a motor-
ized Zeiss Axio Observer.Z1 with AxioVision Rel.4.7 software. All 
frontal images of the embryonic iLN are shown with the epider-
mis facing downward. A list of antibodies used in this study is 
provided in Table S1.
Cell isolation and culture
MEFs from E14.5 embryos were prepared as described previ-
ously (González-Loyola et al., 2015) and cultured in complete 
DMEM. MEFs were used for experiments at passages 1–5. Mouse 
LN LECs were prepared as described (Dubrot et al., 2014), and 
LEC purity was confirmed by staining for LEC-specific PROX1 
and EC-specific ERG. For co-culture experiments, MEFs and LN 
LECs were mixed at 50% in complete αMEM medium, seeded on 
a 6-well plate coated with mixed bovine type I collagen (10 µg/ml; 
Corning) and human plasma fibronectin (10 µg/ml; Sigma), and 
cultured for 24 h. To study paracrine signaling, complete endo-
thelial cell medium or conditioned medium from LECs was added 
to confluent MEFs. To activate lymphotoxin signaling, 2 µg/ml 
of LTβR (clone 4H8; Adipogen) or control antibodies (MOPC21 
muIgG2a) were used.
Cell culture in microfluidic devices
Microfluidic devices were described in and cell seeding proto-
col was adapted from Kim et al. (2016). MEFs were resuspended 
in complete DMEM and fibrinogen solution (2.5 mg/ml) at a 
concentration of 10 million cells/ml and mixed with thrombin 
(1 U/ml; Sigma). The cell mix was injected in the left central 
channel, and all remaining channels were filled with fibrin (2.5 
mg/ml). After fibrin gel polymerization, complete DMEM was 
loaded in the channels and the reservoirs. Devices were kept 
at 37°C in the incubator overnight. The following day, medium 
was replaced with complete DMEM supplemented with 2 µg/
ml of LTβR (clones 4H8 or 3C8; Adipogen) or control antibod-
ies (MOPC21 muIgG2a). To create a 2–3 µm/s interstitial flow 
across the central channels, a pressure gradient was applied by 
transferring the medium between the two channel compart-
ments every 12 h. After 48 h, cells were used for RNA extraction 
or staining. Images were taken using inverted confocal Zeiss 
LSM 880 microscope.
(G) Comparable levels of RAN KL in WT and Foxc2lecKO E18.5 iLNs: RAN KL (green) and LYVE1 (white). E18.5 WT, n = 3; Foxc2lecKO, n = 4. Scale bar, 50 µm. (H) 
Quantification of RAN KL intensity. E18.5 WT, n = 3; Foxc2lecKO, n = 4. (I) Reduced CXCL13 levels in Foxc2lecKO iLNs. Whole mount iLN (1 µm): CD4 (green), CXCL13 
(red), and LYVE1 (white). E18.5 WT, n = 3; Foxc2lecKO, n = 4. Scale bar, 50 µm. (J) Quantification of CXCL13 intensity. E18.5 WT, n = 3; Foxc2lecKO, n = 4. *, P < 0.05. 
(K) Quantification of iLN volume in WT and Foxc2lecKO embryos. E17.5 WT, n = 4; E18.5 WT, n = 3; E18.5 Foxc2lecKO, n = 5. One-way ANO VA test with Tukey post 
hoc test; *, P < 0.05. (L) Quantification of VCAM1 intensity in E17.5 WT versus E18.5 Foxc2lecKO iLNs. WT, n = 4; Foxc2lecKO, n = 5. (M) Quantification of CXCL13 
intensity in E17.5 WT versus E18.5 Foxc2lecKO iLNs. WT, n = 6; Foxc2lecKO, n = 3. *, P < 0.05. (N) Comparable VCAM1 levels in E17.5 WT and E18.5 Foxc2lecKO iLNs. 
Whole mount iLN (5 µm): CD4 (green), VCAM1 (red), and LYVE1 (white). WT, n = 4; Foxc2lecKO, n = 5. Scale bar, 50 µm. (O) Reduced CXCL13 levels in E18.5 
Foxc2lecKO compared with E17.5 WT iLN: CD4 (green), CXCL13 (red), and LYVE1 (white). WT, n = 6; Foxc2lecKO, n = 3. Scale bar, 70 µm. ns, not significant. Data 
are shown as mean ± SD. All quantifications but K used two-tailed unpaired Student’s t test.
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RNA extraction and real-time quantitative PCR (RT-qPCR)
iLNs or skins were dissected from E18.5 embryos and RNA iso-
lated using the Qiagen RNeasy Plus Mini Kit (Qiagen). RNA was 
amplified using Ovation Pico WTA System V2 (Nugen). MEFs 
from chips and cells from co-culture experiments were collected 
using 0.05% trypsin-EDTA (Gibco) and RNA isolated using the 
Qiagen RNeasy Plus Micro or Mini Kit (Qiagen) and reverse 
transcribed using Transcriptor First Strand cDNA Synthesis Kit 
(Roche Diagnostics). We used StepOnePlus (Applied Biosystems) 
and SYBR Green PCR Master Mix (Applied Biosystems) or Sen-
siFAST Sybr Hi-Rox Mix (Bioline) for qPCR analyses. Data were 
analyzed using the comparative Ct (ΔΔCt) method as described 
by the manufacturer. A list of primers used in this study is pro-
vided in Table S2.
Quantifications
Whole embryonic LNs were imaged using confocal Leica SP5 
Tandem microscope. LN size was quantified using Imaris soft-
Figure 9. IFF potentiates Cxcl13 induction in response to LTβ signaling. (A) MEFs were cultured in the left central channel of microfluidic device. Transfer 
of medium from one side to the other of the device creates a hydrostatic pressure gradient and IFF. (B) IFF induces actin stress fibers in MEFs: DAPI (blue) and 
F-actin (green). n = 2. Scale bar, 100 µm. (C) IFF potentiates Cxcl13 expression in response to LTβ signaling. RT-qPCR analysis of the indicated genes after 48 h 
of IFF. Cxcl13, n = 6; LtbR, Vcam1, and Rankl, n = 4. One-way ANO VA test with Tukey post hoc test; *, P < 0.05. (D) Reduced interstitial FITC-dextran transport in 
E18.5 Foxc2lecKO embryos. Arrowheads indicate FITC-dextran–filled lymphatics; asterisks indicate injection sites. Scale bar, 2.5 mm. (E) FITC-dextran lymphatic 
uptake in WT and Foxc2lecKO mice. E18.5, n = 14 per genotype. Data are shown as mean ± SD. Two-tailed unpaired Student’s t test; *, P < 0.05.
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ware. Cell number in iLN area was quantified using Adobe Pho-
toshop and ImageJ software. Skin tissue tiles were imaged with a 
motorized Zeiss Axio Observer.Z1. Skin intralymphatic clusters 
and isolated CD4+ cells were manually analyzed and quantified 
using Adobe Photoshop and ImageJ software. To quantify the 
size and number of Peyer’s patches, images were taken with a 
Leica DMI 3000 B microscope and Leica DFC 3000 G camera 
using LAS X software and analyzed using ImageJ software. For 
proliferation analyses, cells were double-stained for PROX1 and 
EdU. For every LN, whole LNs were analyzed in one transverse 
thick section (19.6 µm thick) at the top LN area and three thick 
sections homogenously distributed from the center of the LN 
(4.5 µm thick). Double PROX1 and EdU masks were applied using 
Imaris software, and cells were quantified using Adobe Photo-
shop and ImageJ software, counting as positive only cells in 
which all PROX1+ area was EdU+. False-positive cells due to par-
tial overlap of PROX1+ cells with adjacent proliferating EdU+ cells 
were excluded. Activated caspase-3 intensity in CD4+ area was 
quantified using Imaris software. For SMC coverage analysis, 
samples were stained for αSMA and endomucin. Double αSMA/
endomucin masks were applied using Imaris software, and 
total endomucin and αSMA/endomucin area were quantified 
using Adobe Photoshop and ImageJ software. For all VCAM1 and 
CXCL13 protein-level analyses at E18.5, five Imaris-generated 
4.5-µm-thick transverse sections per LN were analyzed using 
Adobe Photoshop and ImageJ. For CXCL13 in E17.5 WT and E18.5 
Foxc2lecKO iLNs, ICAM1, and RAN KL protein-level analyses, one 
cryosection per samples was analyzed using Adobe Photoshop 
and ImageJ. Staining intensity was quantified and normalized 
by the area analyzed. For FITC-draining experiments, FITC-
filled lymphatic vessel area was quantified using Adobe Photo-
shop and ImageJ.
Statistics
Number of embryos analyzed is indicated for each image in the 
figure legends. For in vivo experiments comparing animals, we 
used a two-tailed unpaired Student’s t test to determine statistical 
significance by calculating the probability of difference between 
two means. For iLN volume comparing E17.5 WT, E18.5 WT, and 
E18.5 Foxc2lecKO and for SMC coverage comparing Id2-CreERT2 tg/tg 
and Id2-CreERT2 tg/+, we used one-way ANO VA with Tukey post 
hoc test. For in vitro experiments in microfluidic devices, we 
used a one-way ANO VA with Tukey post hoc test. Differences 
were considered statistically significant at P < 0.05. Data are 
shown as mean ± SD.
Online supplemental material
Fig. S1 provides further characterization of LTi cells and blood 
vascular maturation status during early iLN development. Fig. 
S2 provides characterization of intralymphatic CD4+ LTi cells. 
Fig. S3 provides further characterization of lymphatic vessels in 
Foxc2lecKO mice. Fig. S4 shows that LECs reduce MEF expression 
Figure 10. Lymphatic vessels in LN development. (A) LTi cells extravasate from the immature vein to initiate LN formation. At the same time, lymphatic 
vessels take up disseminated LTi cells, extravasating from blood capillaries elsewhere, and transport them to the LN anlage. Later, collecting vessels efficiently 
transport LTi cells to LNs and participate in their expansion. (B) Collecting vessels reorganize into a LN capsule, which engulfs the LN anlage. LN lymphatic 
fluid absorption from blood vessels generates IFF, which increases CXCL13 expression. Loss of Foxc2 impairs LN capsule formation and leads to aberrant SMC 
coverage of LN lymphatic vessels precluding flow-induced CXCL13 production.
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of CXCL13 in response to LTβR activation. Tables S1 and S2 pro-
vide information on antibodies and primers, respectively.
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